Summary
Other Scenarios:
- ZMH - EW
- ZMH - DSCP
- EW - ARRO
- DSCP - ARRO
| Buyer: | Zimmer Holdings, Inc. (ZMH) | Last Price: | 66.45 | Market Cap.: | 15.69B |
|---|---|---|---|---|---|
| Target: | Arrow International, Inc. (ARRO) | Last Price: | 45.48 | Market Cap.: | 2.06B |
Lines of Business Summary:
- Zimmer Holdings, Inc. (ZMH) competes in 1 industry and 44 product/service groups
- Arrow International, Inc. (ARRO) competes in 1 industry and 50 product/service groups
- A combined entity will have 0% Product/Service Group overlap
- Zimmer Holdings, Inc. (ZMH) has 2 and Arrow International, Inc. (ARRO) has 0 suppliers that rely on a material % of their business. They share 0 in common.
- Zimmer Holdings, Inc. (ZMH) has 3 and Arrow International, Inc. (ARRO) has 0 customers that derive significant revenue from each. They share 0 in common.
Product Summary:
Overlap & Complementary Sectors
| Sector | Buyer | Target | # of Focused Companies |
|---|---|---|---|
Healthcare |
|
|
933 |
Biopharmaceuticals |
|
381 | |
Medical Devices |
|
|
253 |
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Sample Products in Similar Lines of Business |
Sample Products in Complementary Lines of Business |
||
Buyer (Total: 151)
|
Target (Total: 86)
|
Buyern/a |
Target
|
Business Relationship Summary:
Top Key Suppliers |
Top Key Customers |
||
Buyer (Total: 7)
|
Target (Total: 3)
|
Buyer (Total: 5)
|
Target (Total: 0)n/a |
Key Financial Summary:
Key Metrics
| Buyer | Target | |
|---|---|---|
| Number of Employees | 6,900 | 4,000 |
| Revenue Per Employee | 525,032.6 | 130,854.5 |
| Total Revenue | 903.2 | 130.5 |
| Total Expenses | 777.2 | 108.4 |
Other Revenue
|
0.0 | 0.0 |
Cost of Revenue
|
199.2 | 64.4 |
SG&A Expense
|
352.6 | 35.8 |
Research & Development
|
53.0 | 7.0 |
Other Operating Expense
|
0.0 | 0.0 |
Operating Income
|
126.0 | 22.1 |
Unusual Income
|
172.4 | 1.2 |
LT Debt to Capital
|
1.93 | 0 |
Fwd P/E
|
16.94 | n/a |
Fwd P/Rev
|
4.07 | n/a |
| Book Value | 5,253.2 | 556.3 |
Curr Portion of LTD/Cap Lease
|
0.0 | 1.0 |
Individual Company Summary
Focused
Buyer
Focused (
):
Healthcare > Medical Devices > Orthopedics > Surgical > Procedure Specific > Joint Replacement/Reconstruction
Target
Focused (
):
Healthcare > Medical Devices > Drug Delivery > Infusion Therapy > Vascular Access
Business Description
Buyer
Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets reconstructive orthopaedic implants, including joint and dental, spinal implants, trauma products and related orthopaedic surgical products. The Company?s products include joint and dental reconstructive orthopaedic implants, spinal implants, trauma products, and related orthopaedic surgical products. Its related orthopaedic surgical products include surgical supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation. Orthopaedic surgeons and neurosurgeons use spinal implants in the treatment of degenerative diseases, deformities and trauma. Trauma products are used primarily to reattach or stabilize damaged bone and tissue to support the body?s natural healing process. In June 2006, Zimmer acquired Musculoskeletal Management Systems, LLC, known as The Human Motion Institute (HMI). HMI is a hospital efficiency consulting business focused on orthopaedics.
Target
Arrow International, Inc. (Arrow) develops, manufactures and markets a range of clinically advanced, disposable catheters and related products for critical and cardiac care. The Company's critical care products are used principally for central vascular access in the administration of fluids, drugs and blood products, patient monitoring and diagnostic purposes. These products are used by anesthesiologists, critical care specialists, surgeons, cardiologists, nephrologists, emergency and trauma physicians, and other healthcare providers. Arrow's cardiac care products are used by interventional cardiologists, cardiac surgeons, interventional radiologists and electrophysiologists for purposes, such as the diagnosis and treatment of heart and vascular disease, and to provide short-term cardiac assist following cardiac surgery, serious heart attack or balloon angioplasty. In October 2007, Teleflex Incorporated completed the acquisition of Arrow.
Deal Summary
Key Ratios
| Buyer | Target | |
|---|---|---|
Gross Margin %
|
77.92 | 50.38 |
Operating Margin %
|
29.65 | 17.71 |
Quick Ratio
|
1.36 | 2.01 |
Current Ratio
|
2.69 | 3.02 |
Coverage Ratio
|
0 | 0.05 |
| Total Assets | 6,367.2 | 726.2 |
| Return on Equity % | 14.36 | 10.98 |
| Return on Assets % | 11.85 | 8.41 |
Cash+ ST Inv. Per Share
|
1.32 | 3.79 |
| Total Debt | 103.2 | 64.9 |
| Total Debt to Equity % | 1.96 | 11.67 |
| Total Debt to Tangible Equity % | 5.28 | 13.73 |
Debt to Asset %
|
1.62 | 8.94 |
Product Summary
| Sector | Buyer | Target |
|---|---|---|
Healthcare |
|
|
Biopharmaceuticals |
|
|
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
|
|
|
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
|
|
|
Medical Devices |
|
|
Anesthesiology
The Anesthesiology Subsector includes medical devices that deliver and monitor anesthetics.
|
|
|
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
|
|
|
Clinical Diagnostics
The Clinical Diagnostics Subsector includes medical devices that analyze human body specimens within a medical setting. These devices, including equipment, biological and chemical reagents are primarily used for the diagnosis of diseases.
|
|
|
Dental
The Dental Subsector includes medical devices that diagnose and treat dental disorders, as well as restore proper function and appearance of teeth and gums.
|
|
|
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
|
|
|
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
|
|
|
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
|
|
|
Neonatology
The Neonatology Subsector includes medical devices that diagnose, monitor and treat diseases of newborns.
|
|
|
Oncology
The Oncology Subsector includes medical devices that detect and treat cancers.
|
|
|
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
|
|
|
Respiratory
The Respiratory Subsector includes medical devices that diagnose and treat respiratory diseases.
|
|
|
Urology
The Urology Subsector includes medical that diagnose and treat urinary tract and male reproductive disorders.
|
|
|
Vascular
The Vascular Subsector includes medical devices that diagnose and treat of conditions affecting the blood vessels.
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Product Details
| Sector | Buyer | Target |
|---|---|---|
Healthcare |
|
|
Biopharmaceuticals |
|
|
Infectious Diseases |
|
|
Bacterial |
|
|
Antibacterial Agents |
|
|
Broad Spectrum |
|
|
Antiseptic Agents
Therapeutics that prevent bacterial infection by inhibiting the growth and development of microorganisms without necessarily killing them.
Target Products:
|
|
|
Surgery |
|
|
General |
|
|
Bacterial Infections |
|
|
Antiseptic Agents
Therapeutics that are used to prevent the spread of microorganism in pre-surgical skin infections due to bacteria.
Target Products:
|
|
|
Medical Devices |
|
|
Anesthesiology |
|
|
Surgical |
|
|
General Procedure |
|
|
Delivery Systems |
|
|
Percutaneous (Subcutaneous/Intramuscular/Intravenous) |
|
|
Pumps/Systems
Devices used to pump intravenous fluids at a consistent programmed rate.
Buyer Products:
|
|
|
Procedure/Region Specific |
|
|
Delivery Systems |
|
|
Epidural
Devices used to inject anesthetic into the epidural space to numb the legs and abdomen, which include catheters, needles, syrninges and other prepackaged kits.
Target Products:
|
|
|
Nerve Block
Devices used to assist in the delivery of nerve block anesthetic, which include catheters, needles and other prepackaged kits.
Target Products:
|
|
|
Cardiology |
|
|
Diagnostic |
|
|
Imaging |
|
|
X-Ray |
|
|
Angiography |
|
|
Accessories
Various instruments used to assist in angiography procedures, including transducers, catheters, control syringes, waste systems, contrast management systems, fluid administration sets, and other related items.
Target Products:
|
|
|
Monitoring |
|
|
Accessories |
|
|
Blood Pressure |
|
|
Invasive Blood Pressure Cuffs
Monitoring accessories that require contact with the blood and blood vessels to obtain an accurate blood pressure reading, such as domes and transducers.
Target Products:
|
|
|
Output Sensors
Instruments that measure various cardiac outputs, such as blood velocity and pressure. Examples of sensors include bioimpedence, hemodynamic and thermodilution catheters.
Target Products:
|
|
|
Monitors |
|
|
Cardiac Output
Instrument that measures the blood flow pumped out of the heart.
Target Products:
|
|
|
Surgical |
|
|
General Procedure |
|
|
Accessories |
|
|
Access |
|
|
Arterial
Instruments used to gain access to the heart's arteries, including aortic pouches, introducer needles, introducers and vessel dilators.
Target Products:
|
|
|
Guidewires
A small wire-like device that is threaded through a catheter to the site of interest for delivery of another apparatus like a stent.
Target Products:
|
|
|
Procedure/Region Specific |
|
|
Arrhythmia |
|
|
Electrophysiology |
|
|
Chamber Mapping Systems |
|
|
Catheters
Long slender wire-like devices with multiple electrodes on the end that gets inserted into the heart chamber for electrophysiological studies and chamber mapping.
Target Products:
|
|
|
Pacing Catheters
Catheter that is capable of regulating the electrical stimulation rhythm of the heart.
Target Products:
|
|
|
Cardiac Output Assist |
|
|
Intra-Aortic Balloon Pump (IABP) |
|
|
Accessories
Various instruments used to assist intra aortic balloon pump surgery, such as catheter kits and introducers.
Target Products:
|
|
|
Systems
Complete set of instruments used to perform intra aortic balloon pump surgery.
Target Products:
|
|
|
Ventricular Assist Device (VAD) |
|
|
Left Ventricular (LVAS) |
|
|
Implantable
A device that can be encased in the body cavity and provides the pumping force for the left ventricle of the heart.
Target Products:
|
|
|
Revascularization |
|
|
Atherectomy |
|
|
Rotational Systems
Complete set of instruments used to perform catheter based rotational blade atherectomy.
Target Products:
|
|
|
Clinical Diagnostics |
|
|
Specimen Collection |
|
|
Blood |
|
|
Arterial |
|
|
ABG Collection Kits
Collection devices used to collect arterial blood samples.
Target Products:
|
|
|
Body Fluids |
|
|
Paracentesis Kits
Kits used in the collection of paracentesis fluid.
Target Products:
|
|
|
Thoracentesis Kits
Catheters/thin tubes used to collect samples of fluid in the thoracic fluid for diagnostic and therapeutic purposes
Target Products:
|
|
|
Dental |
|
|
Surgical |
|
|
Endodontic |
|
|
Irrigation Probes
Probes which provide irrigation during endodontic surgery
Buyer Products:
|
|
|
General |
|
|
Instruments |
|
|
Electrical |
|
|
General Surgical Tools
Devices used to perform general dental surgical procedures, including drills, dryers, composite curing, motors/handpieces, inserts/attachments and other similar items.
Buyer Products:
|
|
|
Manual Instruments
Manual instruments used during dental surgical procedures, including wrenches, drivers, applicators, forceps, knives, pliers and other similar items.
Buyer Products:
|
|
|
Treatment |
|
|
General |
|
|
Hemostatic Sponges
Dressings used during dental procedures.
Buyer Products:
|
|
|
Restorative |
|
|
Accessories |
|
|
Implant Impression Components
Devices used to create an impression or mold to size implants, including impression posts, analogs, and materials.
Buyer Products:
|
|
|
Guided Tissue Regeneration |
|
|
Bone/Soft Tissue Grafts
Grafts of soft tissue or bone which enhance the repair and regeneration of patient tissue.
Buyer Products:
|
|
|
Membranes
Membranes which enhance the repair and regeneration of patient tissue.
Buyer Products:
|
|
|
Implants |
|
|
Abutments
Devices used to support or replace missing teeth.
Buyer Products:
|
|
|
Gingival Cuffs
Cuff like devices which are placed around dental implants which promote healing of the tissue.
Buyer Products:
|
|
|
Healing Screws
Screws used during the placement of implants which promote healing.
Buyer Products:
|
|
|
Implant Bodies (Anchors)
Anchors which are surgically attached to the jaw bone. Implants are then attached to these.
Buyer Products:
|
|
|
Drug Delivery |
|
|
Infusion Therapy |
|
|
Accessories |
|
|
Needleless Fluid Administration/Extension Sets
Valve systems designed to work without needles to prevent patient injuries.
Target Products:
|
|
|
Delivery Systems |
|
|
Pumps |
|
|
Subcutaneous
Pump placed under the skin of the patient receiving infusion therapy.
Target Products:
|
|
|
Integrated/Comprehensive Systems
Complete infusion systems that include pumps, monitoring devices and other accessories.
Target Products:
|
|
|
Vascular Access |
|
|
Extended In Dwelling Catheters |
|
|
Central Venous Catheters (CVC)
Catheters designed to handle high volume flow.
Target Products:
|
|
|
Introducers
Medical devices designed for introducing vascular access.
Target Products:
|
|
|
Kits
Kits containing necessary components for gaining vascular access, such as midline catheters, peripherally inserted central catheters, central venous catheters, and associated repair instruments.
Target Products:
|
|
|
Midline Catheters
Central venous catheter set designed for midline venous access.
Target Products:
|
|
|
Peripherally Inserted Central Catheters (PICC)
Central venous catheter set designed for peripheral venous access.
Target Products:
|
|
|
Peripheral Intravenous Catheters |
|
|
Infusion Sets
Complete infusion sets containing peripheral intravenous catheters.
Target Products:
|
|
|
Ported
Peripheral intravenous catheters that have ports for access and to attach other devices such as infusion pumps.
Target Products:
|
|
|
Safety Catheters
Catheters designed to protect healthcare workers from accidental needle punctures.
Target Products:
|
|
|
Subcutaneous Implants |
|
|
Accessories |
|
|
Port Access
Devices that permit port introduction allowing controlled vascular access.
Target Products:
|
|
|
Ports
Implanted devices that allow controlled vascular access.
Target Products:
|
|
|
General Surgery |
|
|
Invasive |
|
|
Accessories |
|
|
Drainage
Medical instruments used to provide drainage in the surgical area, including access kits, catheters, evacuator kits and reservoirs.
Target Products:
|
|
|
Guidewires
Guidewires used to lead other medical devices into place during surgical procedures
Target Products:
|
|
|
Instruments |
|
|
Manual Instruments
Medical devices used manually by surgeons to perform invasive general surgical procedures, such as scalpels, curettes, dissectors, elevators, forceps, osteotomes, retractors, bissectors and other similar items.
Target Products:
|
|
|
Procedure/Region Specific |
|
|
Cholecystectomy |
|
|
Cholangiography |
|
|
Needles
Needles used to assist in cholangiography.
Target Products:
|
|
|
Minimally Invasive |
|
|
Procedure/Region Specific |
|
|
Cholecystectomy |
|
|
Cholangiography
Devices used to perform minimally invasive procedures involving the biliary system, including catheter kits and other endoscopic instruments.
Target Products:
|
|
|
Medical Supplies |
|
|
Surgical |
|
|
Surgical Preparatory Accessories
Ancillary products designed to clean, prepare and organize surgical instruments and procedures, such as brushes, wipes, cleaners, instrument holders, guards/covers, drapes and other similar items.
Buyer Products:
|
|
|
Treatment |
|
|
Wound Management/First Aid |
|
|
Drainage/Hydration
Medical devices designed to irrigate, moisturize and remove excess fluids from wounds and wound surface.
Buyer Products:
|
|
|
Neonatology |
|
|
Surgical |
|
|
Accessories |
|
|
Drainage Catheters
Long slender wire-like tube device that gains access to internal compartments of a newborn and allows fluid to exit through it.
Target Products:
|
|
|
Treatment |
|
|
Feeding Tubes
A pipe-like instrument that allows food to enter the newborn's stomach.
Target Products:
|
|
|
Urinary Drainage |
|
|
Systems
Complete set of instruments to remove the urine in a newborn's bladder.
Target Products:
|
|
|
Vascular Access |
|
|
Umbilical Vessel Catheters
Long slender wire-like tube device that proceeds down the umbilical cord to provide access to the inside of the newborn.
Target Products:
|
|
|
Oncology |
|
|
Surgical |
|
|
Biopsy |
|
|
Region Specific |
|
|
Liver
Instruments used to obtain biopsy sample from the liver system.
Target Products:
|
|
|
Orthopedics |
|
|
Surgical |
|
|
General Procedure |
|
|
Minimally Invasive/Arthroscopic |
|
|
Instruments |
|
|
Instrument Systems
Orthopedic instruments used for arthroscopic surgical procedures usually sold as a package.
Buyer Products:
|
|
|
Procedure Specific |
|
|
Fixation |
|
|
Bone |
|
|
External |
|
|
General
External fixation devices that can be used to fix a variety of fractures.
Buyer Products:
|
|
|
Internal |
|
|
Absorbable |
|
|
Specific |
|
|
Knee
Internal absorbable fixation device used to immobilize knee fractures.
Buyer Products:
|
|
|
Metallic |
|
|
General
Internal metallic fixation devices or systems that can be used to immobilize various types of bone fractures.
Buyer Products:
|
|
|
Specific |
|
|
Hip/Femur
Internal metallic fixation devices used to immobilize hip or femur fractures.
Buyer Products:
|
|
|
Spine
Internal metallic fixation devices used to immobilize spine fractures.
Buyer Products:
|
|
|
Tibia/Fibula
Internal fixation devices designed for the tibia/fibula bones.
Buyer Products:
|
|
|
Soft Tissue |
|
|
Anchors/Screws |
|
|
Absorbable |
|
|
General
Absorbable anchors/screws used to attach soft tissue to the bone in a variety of regions.
Buyer Products:
|
|
|
Metallic |
|
|
General
Metal devices used to attach soft tissue to the bone in a variety of regions.
Buyer Products:
|
|
|
Joint Replacement/Reconstruction |
|
|
Accessories |
|
|
Allografts |
|
|
Bone
Bone obtained from cadavers to compensate for excessive bone removal.
Buyer Products:
|
|
|
Cartilage
Tissue obtained from cadavers to compensate for excessive tissue removal.
Buyer Products:
|
|
|
Xenografts
Surgical grafts produced from non-human biological material, often used to compensate for excessive bone or tissue removal.
Buyer Products:
|
|
|
Elbow |
|
|
Total Elbow Systems
Devices used to replace the entire ankle joint.
Buyer Products:
|
|
|
Hip |
|
|
Hemi-Arthroplasty |
|
|
Acetabular |
|
|
Bipolar
Devices designed to replace both acetabulum.
Buyer Products:
|
|
|
Unipolar
Devices designed to replace one acetabulum.
Buyer Products:
|
|
|
Femoral
Devices used to replace the ball in the hip joint.
Buyer Products:
|
|
|
Instrument Systems
Instruments used to facilitate either product insertion or removal.
Buyer Products:
|
|
|
Revision Systems |
|
|
Acetabular
Devices used to revise the socket in a previously replaced hip joint.
Buyer Products:
|
|
|
Femoral
Devices used to revise the ball in a previously replaced hip joint.
Buyer Products:
|
|
|
Total Hip Replacement Systems
Devices used to replace the entire hip joint.
Buyer Products:
|
|
|
Knee |
|
|
Instrument Systems
Instruments used to facilitate either product insertion or removal.
Buyer Products:
|
|
|
Revision Systems
Devices used to revise a previously implanted knee replacement.
Buyer Products:
|
|
|
Total Knee Replacement Systems
Devices used to replace the entire knee joint.
Buyer Products:
|
|
|
Unicompartmental Replacement
Devices used to replace a portion of the knee joint as opposed to a total knee replacement.
Buyer Products:
|
|
|
Shoulder |
|
|
Hemi-Arthroplasty |
|
|
Glenoid
Devices used to replace the smooth and shallow depression of the shoulder or glenoid area.
Buyer Products:
|
|
|
Humeral Component
Devices used to replace the humeral component of the shoulder.
Buyer Products:
|
|
|
Humeral Head
Devices used to replace the humeral component of the shoulder.
Buyer Products:
|
|
|
Total Shoulder Replacement Systems
Devices used to replace the entire shoulder joint.
Buyer Products:
|
|
|
Spine |
|
|
Instrument Systems
Instruments used to facilitate either product insertion or removal.
Buyer Products:
|
|
|
Spinal Implants |
|
|
Spinal Fusions
Devices used to fuse together two or more vertebrae in the spine.
Buyer Products:
|
|
|
Respiratory |
|
|
Treatment |
|
|
Pneumothorax Catheter Kits
Thin tubes designed to be inserted into the lungs to correct pneumothorax (collapsed lung).
Target Products:
|
|
|
Urology |
|
|
Surgical |
|
|
Procedure/Region Specific |
|
|
Percutaneous |
|
|
Nephrostomy |
|
|
Drainage Instruments
Instruments used to remove waste fluid from the kidney, such as catheters, malecots, pezzers, nephrostomy tubes and other similar items.
Target Products:
|
|
|
Treatment |
|
|
Renal |
|
|
Hemodialysis |
|
|
Components |
|
|
Access Graft Thrombolysis
Device used to plug up the hole in the access vein used for hemodialysis.
Target Products:
|
|
|
Catheters |
|
|
Central Venous Access (CVA)
Catheter that gains access to a major vein.
Target Products:
|
|
|
Sets
Complete set of catheter instruments used to gain access to internal blood vessels for hemodialysis.
Target Products:
|
|
|
Vascular |
|
|
Diagnostic |
|
|
Imaging |
|
|
X-Ray |
|
|
Angiography |
|
|
Accessories
Various instruments used to assist in angiography procedures, including transducers, catheters, control syringes, waste systems, contrast management systems, fluid administration sets, and other related items.
Target Products:
|
|
|
Surgical |
|
|
General Procedure |
|
|
Accessories |
|
|
Introducer Needles
Devices which provide access to the vascular system for introduction of introducers.
Target Products:
|
|
|
Introducers
Devices used to provide percutaneous introduction of catheters, interventional devices, and temporary pacing leads into the vasculature.
Target Products:
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Relationship Details
Key Competitors
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
Johnson & Johnson
|
|
n/a | 192,824.721 | 18.59 | 16.30 | 3.28 | 3.18 | 13.71 | |
Medtronic, Inc.
|
|
n/a | 56,781.697 | 19.83 | 19.87 | 4.51 | 4.26 | 9.87 | |
Stryker Corporation
|
|
n/a | 31,085.961 | 32.07 | 31.40 | 5.41 | 5.21 | 7.33 | |
Kyocera Corporation (ADR)
|
|
n/a | 16,494.641 | 17.78 | 18.05 | 1.41 | 1.40 | 1.27 | |
Smith & Nephew plc (ADR)
|
|
n/a | 10,352.740 | 29.75 | 22.72 | 3.26 | 3.15 | 36.84 | |
ArthroCare Corporation
|
|
n/a | 1,352.332 | 36.71 | 32.30 | 4.48 | 4.23 | 6.74 | |
Wright Medical Group, Inc.
|
|
n/a | 1,067.139 | 200.40 | 70.24 | 2.88 | 2.78 | 3.15 | |
Orthofix International NV
|
|
n/a | 993.929 | 34.41 | 31.22 | 2.08 | 2.03 | n/a | |
Osiris Therapeutics, Inc.
|
|
n/a | 366.834 | 0.00 | -8.59 | 27.44 | 23.69 | 2,072.51 | |
TranS1 Inc.
|
|
n/a | 321.904 | 0.00 | -20.28 | 23.33 | 20.39 | 22.83 | |
BioMimetic Therapeutics, Inc.
|
|
n/a | 316.309 | 0.00 | -13.60 | 71.57 | 46.52 | 5.05 | |
Exactech, Inc.
|
|
n/a | 237.718 | 29.61 | 26.44 | 2.03 | 1.96 | 2.98 | |
Alphatec Holdings, Inc.
|
|
n/a | 236.449 | 0.00 | -19.62 | 3.04 | 3.02 | 4.10 | |
Lifecore Biomedical, Inc.
|
|
n/a | 185.654 | 23.67 | 23.98 | 2.64 | 2.45 | 2.18 | |
Aastrom Biosciences, Inc.
|
|
n/a | 73.043 | 0.00 | n/a | 110.11 | n/a | 2.94 | |
Straumann A.G.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Mathys Ltd. Bettlach
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Medical Dynamic Marketing, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Target | |||||||||
Edwards Lifesciences Corp
|
|
n/a | 2,618.645 | 22.21 | 22.27 | 2.46 | 2.45 | 6.91 | |
Datascope Corporation
|
|
n/a | 565.187 | 22.86 | 23.53 | 1.49 | n/a | 2.27 | |
ABIOMED, Inc.
|
|
n/a | 504.118 | 0.00 | -17.92 | 9.66 | 8.65 | 6.63 | |
DURECT Corporation
|
|
n/a | 476.186 | 0.00 | -18.79 | 16.12 | 15.24 | 20.05 | |
AngioDynamics, Inc.
|
|
n/a | 456.654 | 0.00 | 32.74 | 3.53 | 2.60 | 3.32 | |
Merit Medical Systems, Inc.
|
|
n/a | 389.380 | 27.99 | 27.50 | 1.91 | 1.89 | 2.73 | |
Delcath Systems, Inc.
|
|
n/a | 43.446 | 0.00 | n/a | n/a | n/a | 2.92 | |
- Defined by the Company
- Defined by Others
Dependent Suppliers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
Tutogen Medical, Inc.
|
|
54.00% | 204.233 | 30.22 | 47.26 | 3.79 | 3.16 | 5.06 | |
Symmetry Medical Inc.
|
|
12.20% | 618.335 | 38.09 | 26.95 | 2.41 | 2.12 | 5.89 | |
Kensey Nash Corporation
|
|
n/a | 366.313 | 184.84 | 37.29 | 5.17 | 4.62 | 3.36 | |
Regeneration Technologies, Inc.
|
|
n/a | 262.635 | 0.00 | 293.67 | 2.99 | 2.83 | 2.51 | |
HealthStream, Inc.
|
|
n/a | 71.882 | 31.40 | 35.11 | 1.77 | 1.60 | 44.15 | |
Atlantis Components, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Revivicor, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Target | |||||||||
Kilroy Realty Corporation
|
|
n/a | 1,725.452 | 36.11 | 16.96 | 6.63 | 6.55 | 2.69 | |
QAD Inc.
|
|
n/a | 306.646 | 70.88 | 58.12 | 1.21 | 1.19 | 7.42 | |
Enturia, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Key Customers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
VHA, Inc.
|
|
32.00% | n/a | n/a | n/a | n/a | n/a | n/a | |
Premier, Inc.
|
|
16.00% | n/a | n/a | n/a | n/a | n/a | n/a | |
HealthTrust Purchasing Group
|
|
8.00% | n/a | n/a | n/a | n/a | n/a | n/a | |
Cynosure, Inc.
|
|
n/a | 326.326 | 30.39 | 24.86 | 2.91 | 2.73 | 3.01 | |
HCA Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Key Partners
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
Integra LifeSciences Holdings Corp.
|
|
n/a | 1,119.902 | 29.30 | 27.06 | 2.16 | 2.07 | n/a | |
Cynosure, Inc.
|
|
n/a | 326.326 | 30.39 | 24.86 | 2.91 | 2.73 | 3.01 | |
Regeneration Technologies, Inc.
|
|
n/a | 262.635 | 0.00 | 293.67 | 2.99 | 2.83 | 2.51 | |
Tutogen Medical, Inc.
|
|
n/a | 204.233 | 30.22 | 47.26 | 3.79 | 3.16 | 5.06 | |
Revivicor, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Atlantis Components, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Premier, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Heraeus Holding GmbH
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Isto Technologies, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Target | |||||||||
King Pharmaceuticals, Inc.
|
|
n/a | 2,512.792 | 14.19 | 5.36 | 1.19 | 1.18 | 1.68 | |
Enturia, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
The Cleveland Clinic Foundation
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Kimal PLC
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Financials
| Buyer | Target | Combined Entity | |
|---|---|---|---|
| Income Statement | |||
| Operating Items | |||
| Revenue | 3,757.6 | 508.0 | 4,265.6 |
Other Revenue
|
0.0 | 0.0 | 0.0 |
| Total Revenue | 3,757.6 | 508.0 | 4,265.6 |
Cost of Revenue
|
829.5 | 252.1 | 1,081.6 |
SG&A Expense
|
1,434.1 | 136.9 | 1,571.0 |
Depreciation & Amortization
|
0.0 | 0.0 | 0.0 |
Research & Development
|
204.4 | 27.2 | 231.6 |
Interest Expense
|
0.0 | 0.0 | 0.0 |
Other Operating Expense
|
0.0 | 0.0 | 0.0 |
Unusual Expense (Income)
|
175.6 | 1.8 | 177.4 |
| Total Expenses | 2,643.6 | 418.0 | 3,061.6 |
Operating Income
|
1,114.0 | 90.0 | 1,204.0 |
| Non Operating Items | |||
Interest Expense (Inc.), Net Non-Oprtng
|
4.4 | 4.7 | 9.1 |
Other, Net
|
0.0 | -1.6 | -1.6 |
| Income Before Taxes | 1,118.4 | 93.1 | 1,211.5 |
| Income Taxes | 363.9 | 32.0 | 395.9 |
| Income After Taxes | 754.5 | 61.1 | 815.6 |
| Minority Interest (IS) | -0.4 | 0.0 | -0.4 |
Net Income - Excl. Xord. Items
|
754.1 | 61.1 | 815.2 |
Net Income - Incl. Xord. Items
|
754.1 | 61.1 | 815.2 |
Income Avail. to Common
|
754.1 | 61.1 | 815.2 |
| Share Items | |||
Basic Avg. Shares Outstanding
|
234.9 | 45.2 | 280.1 |
Basic EPS - Excl. Xord. Items
|
3.21 | 1.35 | 2.91 |
Basic EPS - Incl. Xord. Items
|
3.21 | 1.35 | 2.91 |
| Full Dilution Adjustment | 0.0 | 0.0 | 0.0 |
| Fully Diluted Shares Outstanding | 236.8 | 45.7 | 282.5 |
F.D. EPS - Excl. Xord. Items
|
3.18 | 1.34 | 2.89 |
F.D. EPS - Incl. Xord. Items
|
3.18 | 1.34 | 2.89 |
| Dividends Per Common Share | 0.00 | 0.76 | 0.76 |
| Balance Sheet | |||
| Assets | |||
Cash and Equivalents
|
313.0 | 160.2 | 473.2 |
ST Investments
|
0.0 | 13.2 | 13.2 |
Accounts Receivable
|
652.1 | 104.8 | 756.9 |
Inventory
|
732.2 | 114.0 | 846.2 |
Prepayments and Advances
|
54.5 | 13.5 | 68.0 |
Other Current Assets
|
148.1 | 12.5 | 160.6 |
Current Assets
|
1,899.9 | 418.1 | 2,318.0 |
PPE
|
1,888.8 | 382.7 | 2,271.5 |
Accum D&A
|
-974.8 | -201.6 | -1,176.4 |
PPE, Net
|
914.0 | 181.1 | 1,095.1 |
| Goodwill & Intangibles | 3,298.7 | 83.8 | 3,382.5 |
| Other Assets | 0.0 | 0.0 | 0.0 |
Other LT Assets
|
254.6 | 43.3 | 297.9 |
| Total Assets | 6,367.2 | 726.2 | 7,093.4 |
| Liabilities | |||
| Accounts Payable | 129.0 | 19.0 | 148.0 |
| Payable/Accrued | 0.0 | 0.0 | 0.0 |
| Accrued Expenses | 0.0 | 38.8 | 38.8 |
ST Debt
|
0.0 | 63.9 | 63.9 |
Curr Port of LTD & Cap Lease Oblg
|
0.0 | 1.0 | 1.0 |
| Other (Current) Liabilities | 578.3 | 15.7 | 594.0 |
Current Liab.
|
707.3 | 138.4 | 845.7 |
LT Debt
|
103.2 | 0.0 | 103.2 |
Total LT Debt
|
103.2 | 0.0 | 103.2 |
| Minority Interest (BS) | 2.5 | 0.0 | 2.5 |
| Deferred Taxes | 0.0 | 11.4 | 11.4 |
Other LT Liab.
|
301.0 | 20.2 | 321.2 |
Total Liabilities
|
1,114.0 | 169.9 | 1,283.9 |
| Shareholders Equity | |||
| Common Stock | 2.5 | 45.7 | 48.2 |
| Additional Paid in Capital | 2,976.2 | 45.0 | 3,021.2 |
| Retained Earnings | 3,273.1 | 502.4 | 3,775.5 |
| Treasure Stock | -1,263.5 | -50.7 | -1,314.2 |
| Other Equity | 264.9 | 13.9 | 278.8 |
Total Equity
|
5,253.2 | 556.3 | 5,809.5 |
Total Liab. & Equity
|
6,367.2 | 726.2 | 7,093.4 |
Shares Outstanding
|
234.4 | 45.3 | 279.7 |
| Cash Flow | |||
| Operating Cash Flow | |||
| CF Net Income | 754.1 | 61.1 | 815.2 |
| CF Depreciation | 220.2 | 20.7 | 240.9 |
| CF Amortization | 0.0 | 7.7 | 7.7 |
| CF Deferred Taxes | 0.0 | 0.5 | 0.5 |
| Other Non-Cash Items | 88.1 | 7.7 | 95.8 |
| Change in Working Capital | -152.8 | -7.9 | -160.7 |
| Total Cash From Operating Activities | 909.6 | 89.8 | 999.4 |
| Investing Cash Flow (not calculated) | |||
| Capital Expenditures | -314.9 | -31.2 | -346.1 |
| Other Investing Cash Flows | -129.5 | -14.9 | -144.4 |
| Total Cash From Investing Activities | -444.4 | -46.1 | -490.5 |
| Financing Cash Flow (not calculated) | |||
| Dividends Paid | 0.0 | -32.4 | -32.4 |
| Purchase Or Sale of Stock | -466.8 | 7.4 | -459.4 |
| Purchase and Retirement of Debt | 0.0 | 9.0 | 9.0 |
| Other Financing Cash Flow | 30.8 | 0.2 | 31.0 |
| Total Cash From Financing Activities | -436.0 | -15.8 | -451.8 |
| Exchange Rate Effects | 8.2 | 1.4 | 9.6 |
| Net Change in Cash | 37.4 | 29.4 | 66.8 |
| Cash Taxes Paid | 257.6 | 32.3 | 289.9 |
| Cash Interest Paid | 5.8 | 0.8 | 6.6 |
Johnson & Johnson